Why is Hind.Bio Science falling/rising?
2025-11-29 00:44:17Recent Price Movement and Market Context Hindustan Bio Sciences’ stock price fell by ₹0.20, representing a 3.17% drop as of 08:35 PM on 28 November. This decline marks the continuation of a downward trend, with the stock having lost 6.58% over the past two consecutive trading days. The fall is particularly significant given that the stock has underperformed its sector by 3.72% on the same day, signalling sector-relative weakness. The stock’s performance over the short and medium term further highlights its struggles. Over the past week, the share price has declined by 8.41%, in stark contrast to the Sensex’s modest gain of 0.56%. Similarly, the one-month return shows a 6.15% loss for Hindustan Bio Sciences, while the Sensex advanced by 1.27%. These figures underscore t...
Read MoreWhy is Hind.Bio Science falling/rising?
2025-11-18 22:20:36As of 18-Nov, Hindustan Bio Sciences Ltd is experiencing a decline in its stock price, currently at Rs 6.59, which represents a decrease of -0.34 or -4.91%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of -9.6% during this period. Additionally, it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The stock is also close to its 52-week low, just 1.37% away from Rs 6.5. Notably, investor participation has decreased significantly, with delivery volume dropping by -75.16% compared to the 5-day average, indicating a lack of interest among investors. In the broader market context, Hindustan Bio Sciences Ltd has underperformed relative to the benchmark Sensex, which has gained +0.96% over the past week while the stock has declined by -8.34%. Over the past month, the stock has decrease...
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
02-Feb-2026 | Source : BSEWe are hereby submitting the Newspaper Advertisement in Hitech Edition (English Language) and Prajapalana (Telugu Language) regarding Unaudited Standalone financial results for the Third Quarter ended on December 31 2025
Board Meeting Outcome for Outcome Of Board Meeting
31-Jan-2026 | Source : BSEOutcome of Board Meeting
Un-Audited Results For Quarter Ended 31-12-2025
31-Jan-2026 | Source : BSEUn-audited results for quarter ended 31-12-2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available